(Q51785212)

English

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

scientific article published on 20 February 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Marburgvirus (genus)

0 references

Thomas W Geisbert

14

object named as

Thomas W Geisbert

1 reference

Europe PubMed Central

12 April 2018

author name string

Benoit Callendret

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Jort Vellinga

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Kerstin Wunderlich

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Ariane Rodriguez

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Robin Steigerwald

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Ulrike Dirmeier

6

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Cedric Cheminay

7

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Ariane Volkmann

8

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Trevor Brasel

9

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Ricardo Carrion

10

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Luis D Giavedoni

11

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Jean L Patterson

12

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Chad E Mire

13

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Jay W Hooper

15

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Mo Weijtens

16

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Jutta Hartkoorn-Pasma

17

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Jerome Custers

18

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Maria Grazia Pau

19

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Hanneke Schuitemaker

20

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Roland Zahn

21

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

language of work or name

0 references

publication date

20 February 2018

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

13

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

e0192312

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

copyright license

Creative Commons CC0 License

20 February 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Comparison of platform technologies for assaying antibody to Ebola virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

13 August 2018

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Immunology of protection from Ebola virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Mapping the zoonotic niche of Marburg virus disease in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Mapping the zoonotic niche of Ebola virus disease in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Characterization of host immune responses in Ebola virus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ebola virus vaccines: an overview of current approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Monte Carlo simulation of the Spearman-Kaerber TCID50.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Discovery of an ebolavirus-like filovirus in europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Correlates of immunity to filovirus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Progress in filovirus vaccine development: evaluating the potential for clinical use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Construction and isolation of recombinant MVA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

22 May 2018

Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

13 August 2018

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5819775

29 September 2018

Identifiers

10.1371/JOURNAL.PONE.0192312

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/PMC/5819775

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51785212&oldid=1896170342"